AU2017376455A1 - Platform for identification of biomarkers using navigation tasks and treatments using navigation tasks - Google Patents

Platform for identification of biomarkers using navigation tasks and treatments using navigation tasks Download PDF

Info

Publication number
AU2017376455A1
AU2017376455A1 AU2017376455A AU2017376455A AU2017376455A1 AU 2017376455 A1 AU2017376455 A1 AU 2017376455A1 AU 2017376455 A AU2017376455 A AU 2017376455A AU 2017376455 A AU2017376455 A AU 2017376455A AU 2017376455 A1 AU2017376455 A1 AU 2017376455A1
Authority
AU
Australia
Prior art keywords
individual
environment
navigation
task
data
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017376455A
Other languages
English (en)
Inventor
Titiimaea ALAILIMA
Christian Doeller
Jason Johnson
Walter Edward Martucci
Ashley MATEUS
Matthew OMERNICK
Hugo SPIERS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akili Interactive Labs Inc
Original Assignee
Akili Interactive Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akili Interactive Labs Inc filed Critical Akili Interactive Labs Inc
Publication of AU2017376455A1 publication Critical patent/AU2017376455A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/168—Evaluating attention deficit, hyperactivity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
    • A61B5/4064—Evaluating the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4082—Diagnosing or monitoring movement diseases, e.g. Parkinson, Huntington or Tourette
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/7475—User input or interface means, e.g. keyboard, pointing device, joystick
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/20—Protein or domain folding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Developmental Disabilities (AREA)
  • Psychology (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Data Mining & Analysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Databases & Information Systems (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Social Psychology (AREA)
  • Evolutionary Biology (AREA)
  • Biotechnology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Educational Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
AU2017376455A 2016-12-13 2017-12-13 Platform for identification of biomarkers using navigation tasks and treatments using navigation tasks Abandoned AU2017376455A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662433769P 2016-12-13 2016-12-13
US62/433,769 2016-12-13
PCT/US2017/066214 WO2018112103A1 (en) 2016-12-13 2017-12-13 Platform for identification of biomarkers using navigation tasks and treatments using navigation tasks

Publications (1)

Publication Number Publication Date
AU2017376455A1 true AU2017376455A1 (en) 2019-06-13

Family

ID=62559169

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017376455A Abandoned AU2017376455A1 (en) 2016-12-13 2017-12-13 Platform for identification of biomarkers using navigation tasks and treatments using navigation tasks

Country Status (7)

Country Link
US (2) US12138069B2 (https=)
EP (1) EP3555841A4 (https=)
JP (2) JP7159188B2 (https=)
KR (1) KR102525394B1 (https=)
CN (1) CN110603550A (https=)
AU (1) AU2017376455A1 (https=)
WO (1) WO2018112103A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12399564B2 (en) 2012-08-31 2025-08-26 Blue Goji Llc Treatment of neurological functioning and conditions using computer-assisted dual-task methodology
US11914776B2 (en) 2012-08-31 2024-02-27 Blue Goji Llc System and method for evaluation, detection, conditioning, and treatment of neurological functioning and conditions
KR20200128555A (ko) * 2018-03-04 2020-11-13 아킬리 인터랙티브 랩스 인크. 면역-매개 및 신경-퇴행성 장애를 표적으로 하는 인지 스크린, 모니터 및 인지 치료
US12354729B2 (en) 2018-03-04 2025-07-08 Akili Interactive Labs, Inc. Cognitive screens, monitor and cognitive treatments targeting immune-mediated and neuro-degenerative disorders
CN111990971B (zh) * 2020-09-02 2023-07-07 中国科学院心理研究所 一种基于触屏操作箱视觉空间配对学习的实验与分析方法
CN116077027B (zh) * 2023-02-27 2024-06-28 首都医科大学附属北京友谊医院 一种视觉空间认知能力测试系统及存储介质
CN116363404B (zh) * 2023-03-30 2023-11-21 哈尔滨工业大学 一种识别和量化脑自发活动预测性地图样表征的方法
KR20240152448A (ko) * 2023-04-12 2024-10-22 가톨릭대학교 산학협력단 노인 우울증 환자의 예후를 예측하는 장치 및 그 방법
US12362059B2 (en) 2023-07-17 2025-07-15 NXTech Inc Neurostimulation with gamified self-control training exercises
WO2025081044A1 (en) * 2023-10-13 2025-04-17 Cognivue, Inc. Cognitive screening test for detecting preclinical alzheimer's disease

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2503658A1 (en) 2002-11-05 2004-05-21 University Of Rochester Medical Center Method for assessing navigational capacity
WO2005099576A2 (en) 2004-04-13 2005-10-27 Cambridge University Technical Services Limited Methods for assessing neurocognitive disorders
US20090298025A1 (en) * 2007-05-09 2009-12-03 Oregon Health & Science University Object recognition testing tools and techniques for measuring cognitive ability and cognitive impairment
US20120108909A1 (en) 2010-11-03 2012-05-03 HeadRehab, LLC Assessment and Rehabilitation of Cognitive and Motor Functions Using Virtual Reality
CA2720892A1 (en) 2010-11-12 2012-05-12 The Regents Of The University Of California Enhancing cognition in the presence of distraction and/or interruption
ES2831648T3 (es) * 2010-11-24 2021-06-09 Digital Artefacts Llc Sistemas y métodos para evaluar la función cognitiva
US20120238837A1 (en) * 2011-03-16 2012-09-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware System, devices, and methods for real-time monitoring of cerebrospinal fluid for markers of progressive conditions
ES2928091T3 (es) * 2011-10-09 2022-11-15 Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct Realidad virtual para el diagnóstico de trastornos de movimiento
US20140315169A1 (en) * 2011-11-16 2014-10-23 Veronlque Deborah BOHBOT Computer generated three dimensional virtual reality environment for improving memory
WO2013120075A1 (en) * 2012-02-09 2013-08-15 Anthrotronix, Inc. Performance assessment tool
US20150116316A1 (en) 2013-10-28 2015-04-30 Brown University Virtual reality methods and systems
GB201322094D0 (en) * 2013-12-13 2014-01-29 Electrophoretics Ltd Methods and compositions relating to alzheimers disease
WO2015179522A1 (en) 2014-05-21 2015-11-26 Akili Interactive Labs, Inc. Processor-implemented systems and methods for enhancing cognitive abilities by personalizing cognitive training regimens
US20160078780A1 (en) 2014-09-15 2016-03-17 The Arizona Board Of Regents For And On Behalf Of The University Of Arizona Method and System for Aerobic and Cognitive Training
US20160125748A1 (en) 2014-11-04 2016-05-05 John Wesson Ashford Memory test for Alzheimer's disease
US10449359B2 (en) 2015-01-24 2019-10-22 The Trustees Of The University Of Pennsylvania Method and apparatus for improving cognitive performance
WO2016145372A1 (en) 2015-03-12 2016-09-15 Akili Interactive Labs, Inc. Processor implemented systems and methods for measuring congnitive abilities
US20180284141A1 (en) * 2015-04-02 2018-10-04 Crc For Mental Health Ltd Method for predicting risk of cognitive deterioration
US10661099B2 (en) * 2015-06-16 2020-05-26 Eugene R. Moore Treatment of alzheimer's disease
US20190330335A1 (en) * 2015-10-06 2019-10-31 Alector Llc Anti-trem2 antibodies and methods of use thereof
EP3405185A4 (en) * 2016-01-19 2019-09-18 Thomas Blumenthal BIOMARKERS FOR DOWN SYNDROME AND USES THEREOF
EP3531915B1 (en) 2016-10-24 2024-12-04 Akili Interactive Labs, Inc. Cognitive platform configured as a biomarker or other type of marker
US10401369B2 (en) * 2016-11-08 2019-09-03 Magqu Co. Ltd. Method for discriminating Parkinson's disease dementia from Parkinson's disease with normal cognition

Also Published As

Publication number Publication date
CN110603550A (zh) 2019-12-20
WO2018112103A1 (en) 2018-06-21
US12138069B2 (en) 2024-11-12
JP2020518043A (ja) 2020-06-18
JP7442596B2 (ja) 2024-03-04
EP3555841A1 (en) 2019-10-23
KR20190091354A (ko) 2019-08-05
US20250064378A1 (en) 2025-02-27
JP2023015042A (ja) 2023-01-31
EP3555841A4 (en) 2020-05-20
CA3046789A1 (en) 2018-06-21
KR102525394B1 (ko) 2023-04-24
US20190343447A1 (en) 2019-11-14
JP7159188B2 (ja) 2022-10-24

Similar Documents

Publication Publication Date Title
US20250064378A1 (en) Platform for identification of biomarkers using navigation tasks and treatments using navigation tasks
JP7125390B2 (ja) バイオマーカーまたは他のタイプのマーカーとして構成される認知プラットフォーム
US20250336498A1 (en) Cognitive screens, monitor and cognitive treatments targeting immune-mediated and neuro-degenerative disorders
US20200114115A1 (en) Cognitive platform for deriving effort metric for optimizing cognitive treatment
US11839472B2 (en) Platforms to implement signal detection metrics in adaptive response-deadline procedures
KR20200128555A (ko) 면역-매개 및 신경-퇴행성 장애를 표적으로 하는 인지 스크린, 모니터 및 인지 치료
JP2022506651A (ja) 情動障害のスクリーニングおよび治療のための顔の表情検出
AU2017299614A1 (en) Platforms to implement signal detection metrics in adaptive response-deadline procedures
US12579456B2 (en) Cognitive platform for deriving effort metric for optimizing cognitive treatment
WO2018222729A1 (en) Platform for identification of biomarkers using navigation tasks and treatments based thereon
US20240081706A1 (en) Platforms to implement signal detection metrics in adaptive response-deadline procedures
CA3046789C (en) Platform for identification of biomarkers using navigation tasks and treatments using navigation tasks
HK40019863A (en) Platform for identification of biomarkers using navigation tasks and treatments using navigation tasks
HK40038025A (en) Cognitive screens, monitor and cognitive treatments targeting immune-mediated and neuro-degenerative disorders

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted